{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T04:12:08Z","timestamp":1778991128545,"version":"3.51.4"},"reference-count":32,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"abstract":"<jats:p>PTH has been shown to enhance fracture repair; however, exactly when and where PTH acts in this process remains to be elucidated. Therefore, we conducted a longitudinal, region-specific analysis of bone regeneration in mature, osteopenic rats using a cortical defect model. Six-month-old rats were ovariectomized, and allowed to lose bone for 2 months, before being subjected to bilateral 2-mm circular defects in their femoral diaphyses. They were then treated for 5 wk with hPTH1\u201338 at doses of 0, 3, 10, or 30 \u03bcg\/kg \u00b7 d and scanned weekly by in vivo quantitative computed tomography. Quantitative computed tomography analyses showed temporal, dose-dependent increases in mineralization in the defects, intramedullary (IM) spaces, and whole diaphyses at the defect sites. Histomorphometry confirmed PTH stimulation of primarily woven bone in the defects and IM spaces, but not the periosteum. After necropsy, biomechanical testing identified an increase in strength at the highest PTH dose. Serum procollagen type I N-terminal propeptide concentration showed a transient increase due to drilling, but procollagen type I N-terminal propeptide also increased with PTH treatment, whereas tartrate-resistant acid phosphatase unexpectedly decreased. Analyses of lumber vertebra confirmed systemic efficacy of PTH at a nonfracture site. In summary, PTH dose dependently induced new bone formation within defects, at endocortical surfaces, and in IM spaces, resulting in faster and greater bone healing, as well as efficacy at other skeletal sites. The effects of PTH were kinetic, region specific, and most apparent at high doses that may not be entirely clinically relevant; therefore, clinical studies are necessary to clarify the therapeutic utility of PTH in bone healing.<\/jats:p>","DOI":"10.1210\/en.2008-0814","type":"journal-article","created":{"date-parts":[[2008,11,21]],"date-time":"2008-11-21T02:06:21Z","timestamp":1227233181000},"page":"1570-1579","source":"Crossref","is-referenced-by-count":38,"title":["Longitudinal in Vivo Analysis of the Region-Specific Efficacy of Parathyroid Hormone in a Rat Cortical Defect Model"],"prefix":"10.1210","volume":"150","author":[{"given":"David E.","family":"Komatsu","sequence":"first","affiliation":[{"name":"InMotion Musculoskeletal Institute (D.E.K.), Memphis, Tennessee 38103"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellie A.","family":"Brune","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Liu","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen L.","family":"Schmidt","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bomie","family":"Han","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing Q.","family":"Zeng","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuhao","family":"Yang","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jairo S.","family":"Nunes","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuefeng","family":"Lu","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Geiser","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei L.","family":"Ma","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Wolos","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Westmore","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Sato","sequence":"first","affiliation":[{"name":"Lilly Research Laboratories (K.A.B., H.L., A.L.S., B.H., Q.Q.Z., X.Y., J.S.N., Y.L., A.G.G., Y.L.M., J.A.W., M.S.W., M.S.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2008,11,20]]},"reference":[{"key":"2020071612360953000_R1","first-page":"71","article-title":"Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats.","volume":"19","author":"Kim","year":"1999","journal-title":"Iowa Orthop J"},{"key":"2020071612360953000_R2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bone.2005.06.013","article-title":"Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1\u201334) on chondrogenesis in a model of experimental fracture healing.","volume":"37","author":"Nakazawa","year":"2005","journal-title":"Bone"},{"key":"2020071612360953000_R3","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1359\/jbmr.1999.14.6.960","article-title":"Intermittent parathyroid hormone (1\u201334) treatment increases callus formation and mechanical strength of healing rat fractures.","volume":"14","author":"Andreassen","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071612360953000_R4","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1359\/jbmr.2002.17.11.2038","article-title":"Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1\u201334).","volume":"7","author":"Nakajima","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2020071612360953000_R5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bone.2005.02.002","article-title":"Human parathyroid hormone (1\u201334) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora.","volume":"36","author":"Komatsubara","year":"2005","journal-title":"Bone"},{"key":"2020071612360953000_R6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3928\/0147-7447-20001001-22","article-title":"Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats.","volume":"23","author":"Jahng","year":"2000","journal-title":"Orthopedics"},{"key":"2020071612360953000_R7","first-page":"731","article-title":"Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1\u201334).","volume":"87","author":"Alkhiary","year":"2005","journal-title":"J Bone Joint Surg Am"},{"key":"2020071612360953000_R8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/00016470152846673","article-title":"Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone.","volume":"72","author":"Andreassen","year":"2001","journal-title":"Acta Orthop Scand"},{"key":"2020071612360953000_R9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bone.2007.08.041","article-title":"Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.","volume":"42","author":"Nozaka","year":"2008","journal-title":"Bone"},{"key":"2020071612360953000_R10","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/jor.20427","article-title":"Role of parathyroid hormone in the mechanosensitivity of fracture healing.","volume":"25","author":"Gardner","year":"2007","journal-title":"J Orthop Res"},{"key":"2020071612360953000_R11","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1359\/jbmr.070724","article-title":"Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures.","volume":"22","author":"Kakar","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2020071612360953000_R12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/jor.20420","article-title":"Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing.","volume":"25","author":"Tsiridis","year":"2007","journal-title":"J Orthop Res"},{"key":"2020071612360953000_R13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bone.2007.01.015","article-title":"Human parathyroid hormone (1\u201334) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys.","volume":"40","author":"Manabe","year":"2007","journal-title":"Bone"},{"key":"2020071612360953000_R14","author":"Eli Lilly and Co.","year":"2002"},{"key":"2020071612360953000_R15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bone.2003.08.012","article-title":"Detecting and tracking local changes in the tibiae of individual rats: a novel method to analyse longitudinal in vivo micro-CT data.","volume":"34","author":"Waarsing","year":"2004","journal-title":"Bone"},{"key":"2020071612360953000_R16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bone.2006.04.017","article-title":"Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography.","volume":"39","author":"Boyd","year":"2006","journal-title":"Bone"},{"key":"2020071612360953000_R17","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1359\/jbmr.2003.18.9.1622","article-title":"Noninvasive in vivo monitoring of bone architecture alterations in hindlimb-unloaded female rats using novel three-dimensional microcomputed tomography.","volume":"18","author":"David","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2020071612360953000_R18","first-page":"123","article-title":"In vivo longitudinal assessment of bone resorption in a fibular osteotomy model using micro-computed tomography.","volume":"25","author":"Powell","year":"2005","journal-title":"Iowa Orthop J"},{"key":"2020071612360953000_R19","author":"Rasband","year":"1997\u20132007"},{"key":"2020071612360953000_R20","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1021\/pr070288s","article-title":"Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity.","volume":"6","author":"Han","year":"2007","journal-title":"J Proteome Res"},{"issue":"Suppl","key":"2020071612360953000_R21","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/00003086-199810001-00007","article-title":"Experimental models of fracture repair","volume":"355","author":"Nunamaker","year":"1998","journal-title":"Clin Orthop Relat Res"},{"issue":"Suppl 2","key":"2020071612360953000_R22","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1007\/s00198-005-1859-7","article-title":"Animal models for fracture treatment in osteoporosis","volume":"16","author":"Egermann","year":"2005","journal-title":"Osteoporos Int"},{"key":"2020071612360953000_R23","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1185\/03007990802115796","article-title":"Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I.","volume":"24","author":"Boonen","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"2020071612360953000_R24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1292\/jvms.63.603","article-title":"Molecular analysis of defect healing in rat diaphyseal bone.","volume":"63","author":"Chiba","year":"2001","journal-title":"J Vet Med Sci"},{"key":"2020071612360953000_R25","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bone.2004.01.002","article-title":"Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats.","volume":"34","author":"Tanaka","year":"2004","journal-title":"Bone"},{"key":"2020071612360953000_R26","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1210\/endo.138.10.5440","article-title":"Biosynthetic human parathyroid hormone (1\u201334) effects on bone quality in aged ovariectomized rats.","volume":"138","author":"Sato","year":"1997","journal-title":"Endocrinology"},{"key":"2020071612360953000_R27","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1210\/endo.139.11.6307","article-title":"LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1\u201334).","volume":"139","author":"Sato","year":"1998","journal-title":"Endocrinology"},{"key":"2020071612360953000_R28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.bone.2006.11.027","article-title":"PINP: a serum biomarker of bone formation in the rat.","volume":"40","author":"Hale","year":"2007","journal-title":"Bone"},{"key":"2020071612360953000_R29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bone.2007.11.017","article-title":"Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation.","volume":"42","author":"Pettway","year":"2007","journal-title":"Bone"},{"key":"2020071612360953000_R30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcb.10490","article-title":"Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone.","volume":"89","author":"Locklin","year":"2003","journal-title":"J Cell Biochem"},{"key":"2020071612360953000_R31","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1359\/jbmr.2002.17.5.808","article-title":"Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.","volume":"17","author":"Iida-Klein","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2020071612360953000_R32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/104454903322405428","article-title":"Administration of parathyroid hormone, prostaglandin E2, or 1-\u03b1,25-dihydroxyvitamin D3 restores the bone inductive activity of rhBMP-2 in aged rats.","volume":"22","author":"Kabasawa","year":"2003","journal-title":"DNA Cell Biol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/150\/4\/1570\/9001882\/endo1570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/150\/4\/1570\/9001882\/endo1570.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T21:42:58Z","timestamp":1632260578000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/150\/4\/1570\/2455628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,20]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2008-0814","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,20]]}}}